Variant report
Variant | nsv1028176 |
---|---|
Chromosome Location | chr9:1549908-1583224 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs573336900 | chr9:1549945-1549946 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs189934921 | chr9:1549947-1549948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs116371332 | chr9:1549987-1549988 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs558055747 | chr9:1550014-1550015 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs578010344 | chr9:1550041-1550042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs568041779 | chr9:1550048-1550049 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs146130597 | chr9:1550053-1550054 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs140113579 | chr9:1550061-1550062 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs542748529 | chr9:1550069-1550070 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs117373942 | chr9:1550079-1550080 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs375827667 | chr9:1550099-1550100 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs545220333 | chr9:1550109-1550110 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs565205550 | chr9:1550130-1550131 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs143938664 | chr9:1550157-1550158 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs547468227 | chr9:1550196-1550197 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs567690174 | chr9:1550208-1550209 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs182106722 | chr9:1550240-1550241 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs550274903 | chr9:1550241-1550242 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs570184338 | chr9:1550271-1550272 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs538004072 | chr9:1550285-1550286 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs79555899 | chr9:1550299-1550300 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs571520593 | chr9:1550319-1550320 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs10962025 | chr9:1550320-1550321 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs114029449 | chr9:1550337-1550338 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs573616958 | chr9:1550342-1550343 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs17723131 | chr9:1550403-1550404 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs74425086 | chr9:1550412-1550413 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs146871900 | chr9:1550436-1550437 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs115021210 | chr9:1550437-1550438 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs545160596 | chr9:1550534-1550535 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs371179999 | chr9:1550546-1550547 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs72692348 | chr9:1550549-1550550 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs561394558 | chr9:1550561-1550562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs530245446 | chr9:1550563-1550564 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs148520378 | chr9:1550604-1550605 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs189516337 | chr9:1550605-1550606 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs180696332 | chr9:1550621-1550622 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs561102097 | chr9:1550638-1550639 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs73386022 | chr9:1550655-1550656 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs142787008 | chr9:1550664-1550665 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs570123943 | chr9:1550698-1550699 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs185319199 | chr9:1550724-1550725 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs551599281 | chr9:1550736-1550737 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs151026120 | chr9:1550756-1550757 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs140990790 | chr9:1550770-1550771 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs540386641 | chr9:1550789-1550790 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs532747906 | chr9:1550807-1550808 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs567473089 | chr9:1550817-1550818 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs550930737 | chr9:1550818-1550819 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs536212670 | chr9:1550858-1550859 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian cancer | 21720365 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Melanoma | 18172304 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Williams-beuren syndrome | 18553513 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Pilocytic astrocytoma | 18622384 | CNVD |
Pilomyxoid astrocytoma | 18622384 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
prenatal diagnosis | 20453657 | CNVD |
Gastric cancer | 16715143 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Non-small cell lung cancer | 21952639 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
abnormal development | 18461090 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 20531469 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Renal cell carcinoma | 21215367 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:1549400-1558600 | Weak transcription | Adipose Nuclei | Adipose |
2 | chr9:1550600-1551000 | Enhancers | Fetal Muscle Leg | muscle |
3 | chr9:1551000-1553200 | Weak transcription | Fetal Muscle Leg | muscle |
4 | chr9:1553200-1554600 | Enhancers | Fetal Muscle Leg | muscle |
5 | chr9:1553200-1555200 | Enhancers | Fetal Lung | lung |
6 | chr9:1553600-1554000 | Enhancers | Fetal Stomach | stomach |
7 | chr9:1554000-1554600 | Enhancers | Fetal Kidney | kidney |
8 | chr9:1558400-1559200 | ZNF genes & repeats | HUES6 Cell Line | embryonic stem cell |
9 | chr9:1558600-1558800 | ZNF genes & repeats | Adipose Nuclei | Adipose |
10 | chr9:1574600-1575000 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
11 | chr9:1575400-1576200 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
12 | chr9:1575800-1576200 | ZNF genes & repeats | iPS DF 6.9 Cell Line | embryonic stem cell |
13 | chr9:1579800-1580200 | Enhancers | GM12878-XiMat | blood |
14 | chr9:1580200-1580600 | Active TSS | GM12878-XiMat | blood |